Teva Pharmaceutical Industries Ltd. (Nasdaq:
TEVA) offered a premium of approximately $40 billion to acquire Mylan
(Nasdaq: MYL). Shares of Teva rose 87 cents to close at $64.16 while
Mylan stock jumped $6.03 to close at $74.07.
Teva offers premium for Mylan
April 21, 2015 at 17:22 PM EDT
